NCT00882310 A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00878657 Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT00871169 Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00867126 Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine Status TERMINATED Phase EARLY_PHASE1
NCT00862524 A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00855634 Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München Status TERMINATED Phase NA
NCT00851955 Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer Status COMPLETED Phase N/A
NCT00841035 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients Status TERMINATED Phase PHASE2
NCT00837876 Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00836992 Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer Status COMPLETED Phase N/A
NCT00836407 Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00831571 Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin Status COMPLETED Phase N/A
NCT00831493 Vorinostat Plus Radiation Therapy in Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00830557 Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders Status RECRUITING Phase N/A
NCT00826982 Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer Status COMPLETED Phase N/A
NCT00819169 QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT00813696 Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE3